• Mashup Score: 1
    Podcasts - 2 year(s) ago

    ASCO Podcasts deliver timely information to keep you up to date on the latest changes, challenges, and advances in oncology. Listen on the go to interviews and insights from thought leaders, innovators, and experts in oncology.

    Source: ASCO
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JCO_ASCO
      JCO_ASCO

      🥳 Happy #InternationalPodcastDay! Send a tweet to your favorite #JCO and @JCOPO_ASCO podcast hosts! 🎙️ JCO Cancer Stories: @l_schapira JCO Podcast: @ShannonWestin #JCOPO Conversations: @thenasheffect  View our full podcast lineup: https://t.co/o8BlxqsWu8 https://t.co/VO41rduC9w

  • Mashup Score: 1
    Targeting Anaplastic Lymphoma Kinase in GI Primary Malignancies - 2 year(s) ago

    In the era of precision oncology, tumors are increasingly profiled and treated on the basis of their molecular signatures as opposed to the primary site of origin. The anaplastic lymphoma kinase (ALK) signaling pathway, initially discovered in anaplastic large cell lymphoma, has been the poster child for targeted therapy development. The ALK receptor tyrosine kinase is associated with downstream…

    Source: JCO Precision Oncology
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CyclingDoctor
      CyclingDoctor

      RT @JCOPO_ASCO: #JCOPO Editorial on targeting #ALK in primary GI malignancies ➡️ https://t.co/Qa7O6GbwME #gicsm #lymsm https://t.co/5YkghfN…

  • Mashup Score: 1
    JCO Precision Oncology Celebrates 5 Years Capturing the Emergence of Personalized Cancer Care - 2 year(s) ago

    “In our first 5 years, we’ve impacted both the study and the practice of precision oncology and been able to highlight both successes and remaining challenges in the field, helping us to focus on areas for future study,” said founding editor-in-chief Dr. James M. Ford.

    Source: ASCO Connection
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCO
      ASCO

      🎉 @JCOPO_ASCO celebrates 5 years since its launch, with a vision to advance #precisiononcology and define genomics-driven clinical care of patients with cancer. Read more about the #JCOPO's advancements: https://t.co/Qf2lVv4RkI #ASCOConnection #precisionmedicine

  • Mashup Score: 0
    Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples - 2 year(s) ago

    PURPOSE Tissue-based comprehensive genomic profiling (CGP) is increasingly used for treatment selection in patients with advanced cancer; however, tissue availability may limit widespread implementation. Here, we established real-world CGP tissue availability and assessed CGP performance on consecutively received samples. MATERIALS AND METHODS We conducted a post hoc, nonprespecified analysis of…

    Source: JCO Precision Oncology
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples [Aug 19, 2021] Tomlins et al. @StrataOncology #JCOPO @ASCO_pubs https://t.co/wxBKjmvEOa #PrecisionMedicine #oncopath #camoldx

  • Mashup Score: 0
    Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non–Small-Cell Lung Cancer Harboring MET Exon 14 Skipping - 2 year(s) ago

    PURPOSE MET exon 14 skipping alterations (METex14) comprise a diverse set of actionable oncogene drivers in non–small-cell lung cancer (NSCLC). Recent studies have established the efficacy of tyrosine kinase inhibitors for this patient population. The landscape of co-occurring genetic alterations in METex14 NSCLC and their potential impact to therapeutic sensitivities has not yet been fully…

    Source: JCO Precision Oncology
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of StephenVLiu
      StephenVLiu

      Report in #JCOPO led by Dr. @LeXiuning describes landscape of almost 700 #METex14 NSCLC, noting co-occurring amplification and co-mutations. Interesting to see familiar drivers also mediate resistance for other drivers. Grateful for the collaboration. https://t.co/3bBK5wkxVN

  • Mashup Score: 0
    Implementation and Clinical Utility of an Integrated Academic-Community Regional Molecular Tumor Board - 3 year(s) ago

    Purpose Precision oncology develops and implements evidence-based personalized therapies that are based on specific genetic targets within each tumor. However, a major challenge that remains is the provision of a standardized, up-to-date, and evidenced-based precision medicine initiative across a geographic region. Materials and Methods We developed a statewide molecular tumor board that…

    Source: JCO Precision Oncology
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Implementation & Utility of an Integrated Academic-Community #PrecisionMedicine MTB [Jul 5, 2017] @meburkard et al. #JCOPO @ASCO_pubs https://t.co/HOWIx7KvmM

Load More